Disseminating your research findings to a range of stakeholders is an important part of the research impact process. The key is to think about ‘who’ might possibly benefit from knowing more about your research, and importantly, ‘how’ could they use your findings to support, inform and develop their practice.
A good example of this process is the recent keynote address delivered by Prof. John Oliver (FMC) to more than 60 delegates at a one-day event that launched the new Centre of Excellence, Enterprise Portfolio Management Office (UK Parliament). Prof. Oliver’s talk entitled ‘Harnessing the Power of Scenario Planning’ presented the findings of his scenario-planning project that ultimately developed a mission, vision and strategy for the House of Commons Library Service in UK Parliament. Additional keynotes were given by the Chief Operating Officer (House of Lords) and a range of internal and external experts on project delivery and digital transformation.
Prof. Oliver’s work is published in Oliver, J.J., Reid, M., and Gray, K. (2023). The Library of the Future: a scenario-based approach. Journal of Library Administration, Volume 63, Issue 1, Pages
27-41













Innovative Approaches to Doctoral Supervision: Selected Case Studies
3C Event: Research Culture, Community & Canapés-Tuesday 19 May 1-2pm
New chapters published in maternity book on risk
The British Academy European Research Council Grant Support Sessions
Grant Writing Workshops: Master the Art of the Winning Proposal
UKCGE Recognised Research Supervision Programme: New Application Window
Apply now to take part in the 2026 ESRC Festival of Social Science
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease